Navigation Links
Cephalon Reports Record Earnings and Raises 2010 Guidance
Date:10/28/2010

(4)(12)Generic OTFC

32,609-32,60966,834-66,834(51)0(51)Other Generic Pain

-42,73842,738-6,2596,2590583583Pain

273,366108,289381,655307,01961,492368,511(11)764OncologyProprietary OncologyTREANDA

284,900-284,900160,549-160,54977-77Other Proprietary Oncology

15,93157,29073,22113,53053,73367,2631879Generic Oncology

-15,41015,410-14,68514,685-55Oncology

300,83172,700373,531174,07968,418242,49773654OtherOther Proprietary

11,2224,10815,33013,277-13,277(15)-15Other Generic

10,680199,122209,80212,88981,58394,472(17)144122Other

21,902203,230225,13226,16681,583107,749(16)149109$  1,533,322$
462,871$  1,996,193$  1,308,412$
280,198$  1,588,61017%65%26% Europe- Primarily Europe, Middle East and Africa Proprietary products are products which are sold under patent coverage.   Generic products are products sold without patent coverage in the primary sales territory. Patent coverage may exist in other territories.   CEPHALON, INC. AND SUBSIDIARIESCONSOLIDATED BALANCE SHEETS(In thousands, except share data)(Unaudited)September 30, December 31, 20102009CURRENT ASSETS:   Cash and cash equivalents

$
,208,990$
,647,635   Receivables, net

450,614376,076   Inventory, net

295,880240,576   Deferred tax assets, net

225,031243,246   Other current assets

66,78758,423Total current assets

2,247,3022,565,956   INVESTMENTS

12,59412,427   PROPERTY AND EQUIPMENT, net

500,013451,879   GOODWILL

833,358590,284   INTANGIBLE ASSETS, net

1,234,181981,857   DEBT ISSUANCE COSTS

15,36218,862   OTHER ASSETS

43,58236,830$
4,886,392$
4,658,095CURRENT LIABILITIES:   Current portion of long-term debt, net

$
44,097$
818,925   Accounts payable

100,91788,829   Accrued expenses

507,408430,209Total current liabilities

<
'/>"/>
SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
2. Cephalon Announces Chairman and CEO to Take Medical Leave of Absence
3. Cephalon Completes Acquisition of Arana Therapeutics
4. Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings
7. Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes
8. Cephalons New Product Launches Pace Record 2008 Sales
9. Cephalon Appoints Sarma P. Duddu as General Manager and Vice President of Drug Delivery Technologies for CIMA LABS
10. Cephalon Exercises Option to License Worldwide Rights to ImmuPharma Product, Lupuzor
11. Cephalon and Eurand File Patent Infringement Lawsuit Against Mylan Pharmaceuticals and Barr Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015 Imagine being able to ... those of others. Being able to read faces and ... people to anticipate their thoughts and actions like never ... feelings to create unique abstract paintings and video, or, ... inside a first-person-shooter as it creates action, dialog, and ...
(Date:5/21/2015)... (PRWEB) May 21, 2015 Patent Offering, ... method for diagnostic or therapeutic imaging within a body ... uses an endoscope having a low cost, single-use disposable ... filing date was October 18, 2013 and the patent ... technology enables the physician to customize the lighting and ...
(Date:5/21/2015)... SURPRISE, ARIZ. (PRWEB) May 21, 2015 ... E. Webb Medical Center (BDWMC), Sun Health Foundation funded ... medical center’s new inpatient pharmacy with the most up-to-date ... to open June 2. The pharmacy's 45 staff members ... much larger 4,895-square-foot space in the coming days. ...
(Date:5/21/2015)... - RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: ... on the development of autologous cell therapies, announced ... Society for Cellular Therapy (ISCT) on RepliCel,s autologous ... a Phase 1/2 clinical trial.  The presentation, taking ... PM to 7:00 PM local time, will review ...
Breaking Biology Technology:5 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 2IpAuctions™ Presents The Worlds Smallest Disposable Illuminated Endoscope For Auction 3Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 2Sun Health Foundation Provides $3.25M to Expand, Relocate Banner Del E. Webb Medical Center Pharmacy 3RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3
... MITI ), today announced that its President and CEO, Dr. Christian Itin, ... in New York City on Tuesday, February 10, 2009. A simultaneous webcast ... www.micromet-inc.com ., Forum: The BIO CEO ... 10, 2009, Time: 2:15 pm, ...
... In a paper published in the most recent issue of ... M. McGuire and James H. Kelly describe the need and ... three times as many patients on the waiting list for ... to stabilize them if they enter an acute phase of ...
... OREX ), a biopharmaceutical company focused on the treatment of,obesity, ... Annual,BIO CEO & Investor Conference. The details are as follows: , ... Monday, February 9, 2009, Time: 3:45 p.m. ... Room, New York, Speaker: Graham Cooper, Chief Financial ...
Cached Biology Technology:Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 2Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 3Micromet to Present at the BIO CEO and Investor Conference on February 10, 2009 4Stem Cell Innovations' PluriCells(TM) to Form the Basis of a Liver Assist Device to Support Patients Waiting for Transplant. 2Stem Cell Innovations' PluriCells(TM) to Form the Basis of a Liver Assist Device to Support Patients Waiting for Transplant. 3
(Date:4/27/2015)... 27, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces that ... customers the first week of May, 2015 and will ... May. Gino Pereira , Chief ... the company as Wocket® enters the consumer market. We ...
(Date:4/20/2015)... April 20, 2015 The announcement ... Glenbeigh Records Management (GRM), Ireland,s ... Islamic Bank. Having built up an impressive track record of ... leading player within the records management sector in ... double is GCC staffbase and employ a further eight staff ...
(Date:4/13/2015)... , April 13, 2015 ... TechSci Research, "Global Biometrics Market Forecast & Opportunities, 2020", ... a CAGR of around 14% till 2020. The ... for large scale implementation and review of biometric ... launch of new products with greater efficiency, are ...
Breaking Biology News(10 mins):Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... decision-making tools for public health officials. As demonstrated ... models can be useful in two ways: they ... and they can allow the comparison of alternative ... assumptions that may systematically bias their predictions, say ...
... were overloaded with excess fluid have led UCSF pediatricians ... the process, they have discovered a rare type of ... cause two different, opposite genetic disorders. , The new ... described in the May 5 issue of The New ...
... models have become invaluable decision-making tools for public ... foot-and-mouth epidemic of 2001, models can be useful ... characteristics of an infection and they can allow ... such models make implicit assumptions that may systematically ...
Cached Biology News:Inhaling large amounts of salt can cause hypertension 2Newly discovered genetic disease sheds light on body's water balance 2Newly discovered genetic disease sheds light on body's water balance 3Newly discovered genetic disease sheds light on body's water balance 4Newly discovered genetic disease sheds light on body's water balance 5Understanding biases in epidemic models important when making public health predictions 2
... EtBr Spin Columns provide a rapid and simple ... (100 bp to 10 kb) from stained agarose ... is excised from an agarose gel and loaded ... of the column are a series of membranes ...
This depletion cocktail is tailored to deplete IgE-bearing (I.e. basophils and mast cells) from whole blood...
... efficient extraction of DNA from agarose gels The ... fragments of 150 bp to > 12,000 bp in ... to dissolve the gel slice, followed by adsorption of ... column format. After a wash step, the purified DNA ...
This kit is designed to select cells labeled with fluorescein isothiocyanate- (FITC-) conjugated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
Biology Products: